Hans E Grossniklaus (Hans Grossniklaus)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Diffusion Weighted Imaging

Liver Metastases

Top Venues

Annals of eye science

Cancer gene therapy

Eye (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriel J Starrett, Brittany C Baikie, Benjamin K Stoff, Hans E Grossniklaus, Inga Van Buren, Elizabeth G Berry, Roberto A Novoa, Kerri E Rieger, Kavita Y Sarin, Charles F Lynch, Michael C Royer, Mary L Piaskowski, Isaac Brownell, Emily Y Chu, Rama Godse, Suephy C Chen, Kelly J Yu, Alisa M Goldstein, Eric A Engels, Michael R Sargen
Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hua Yang, Shanshan Tan, Jingjuan Qiao, Yiting Xu, Zongxiang Gui, Yuguang Meng, Bin Dong, Guangda Peng, Oluwatosin Y Ibhagui, Weiping Qian, Jimmy Lu, Zezhong Li, Guimin Wang, Jinping Lai, Lily Yang, Hans E Grossniklaus, Jenny J Yang
Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging. Cancer gene therapy (2022)
Ogul E Uner, Nikhila Gandrakota, Corrina P Azarcon, Hans E Grossniklaus
Animal Models of Uveal Melanoma. Annals of eye science 7 (2022)
Gustav Stålhammar, Hans E Grossniklaus
Overrepresentation of human epidermal growth factor receptor 2 positive- and Luminal B breast cancer metastases in the eyes and orbit. Eye (London, England) (2022)
Ravi Chakra Turaga, Ganesh Satyanarayana, Malvika Sharma, Jenny J Yang, Shiyuan Wang, Chunfeng Liu, Sun Li, Hua Yang, Hans E Grossniklaus, Alton Brad Farris, Jordi Gracia-Sancho, Zhi-Ren Liu
Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment. Communications biology 4 (1) (2021)